Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


Yaz & Yasmin Birth Control Contraceptive

yaz yasmin informationYaz and Yasmin are popular birth control drugs sold by the German pharmaceutical company Bayer Healthcare. Yasmin was approved by the FDA in 2001 and Yaz in 2006. Since then, the two drugs have been prescribed to as many as 100 million women.

Yaz and Yasmin are classified as Combination Oral Contraceptives (COCs), which use the steroids estrogen and progestin to prevent ovulation and pregnancy. These were designed and marketed as safer forms of birth control with fewer side effects than traditional oral contraceptives.

Unfortunately, experts have now warned that the progestin hormone in Yaz, drospirenone, may increase the risk for blood clots, strokes, deep vein thrombosis (DVT) and pulmonary embolism.


Yaz & Yasmin Litigation Overview

As news of Yaz side effects grew, more than 10,000 women filed lawsuits over their injuries in a special federal court. Bayer began settling these lawsuits in 2012 and is continuing to compensate patients with certain injuries. Lawyers are still helping those affected file claims.

If you suffered a blood clot, stroke, pulmonary embolism or DVT after taking Yaz, it is important to speak with a lawyer about your legal options and what compensation is available. Contact us today for more information.

The FDA has received hundreds of reports of Yaz or Yasmin patients suffering injury or death due to blood clots. They have now issued warnings to Bayer and required label changes to address these risks on three occasions.

On October 25, 2011, The British Medical Journal published a study from the University of Copenhagen which highlighted Yaz side effects, finding that the hormone in the birth control drugs increased risks of blood clots.

The FDA then released its own study of more than 800,000 women on October 27, 2011, which showed that drugs like Yaz containing drospirenone could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.

On May 31, 2012, the Institute for Safe Medicine Practices reported that Yaz and Yasmin ranked second highest in 2011 for the number of complications reported to the FDA.

According to an annual report to shareholders provided by Bayer in July, 2012, the company has begun settling Yaz side effect cases at an average of $212,000. These lawsuits will cost Bayer as much as $1.2 billion.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Resource Center or speak with a lawyer about their legal options.

Lawsuits for defective drug injuries can be complex legal matters. Before choosing a lawyer, make sure they are qualified to handle this type of case, have experience fighting large drug companies, and have the resources to finish your case.

The Drug Resource Center works with only the top defective drug law firms in the country to make sure your case is handled properly and you recover quickly.

Contact us today for more information on Yaz, the side effects of the drug, and current litigation. We are available 24 hours a day to provide help.

Authored by Chris Schroeder